CRIS
Curis Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$2.770
Kõrge
$2.770
Madal
$2.770
Maht
0.05M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
HC Wainwright & Co. Assumes Curis at Buy, Announces Price Target of $17
HC Wainwright & Co. analyst Joseph Pantginis assumes Curis with a Buy rating and announces Price Target of $17.
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...
Curis Provides First Quarter 2025 Business Update
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...
Seotud aktsiad
NEWTI
NewtekOne Inc. 8.00% Fixed Rate Senior Notes due 2028
XOMAO
XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
RPTX
Repare Therapeutics Inc. Common Shares
PBI
Pitney Bowes Inc.
CGEM
Cullinan Therapeutics Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.